SWP
GCVRZ

Stratos Wealth Partners’s Sanofi Contingent Value Rights GCVRZ Stock Holding History

Stratos Wealth Partners’s Portfolio GCVRZ Stock Details GCVRZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-297
Closed – – 3094
2018
Q3 		$0 Buy
+297
New +$159 ﹤0.01% 3109
2018
Q2 		– Sell
-311
Closed – – 3223
2018
Q1 		$0 Sell
311
-100
-24% -$40 ﹤0.01% 3350
2017
Q4 		$0 Buy
+411
New +$156 ﹤0.01% 2885

Other funds holding GCVRZ

SCM
Stonehill Capital Management New York $197M AUM 96.45% 1-Year Est. Return
EM
Elliott Management New York $11.8B AUM 20.29% 1-Year Est. Return
MCM
Mason Capital Management New York $613M AUM 21.43% 1-Year Est. Return
TGHSA
TPG Group Holdings (SBS) Advisors Fort Worth, Texas $10.1B AUM 22.58% 1-Year Est. Return
BCM
Brigade Capital Management New York $806M AUM 20.71% 1-Year Est. Return
HCM
Highbridge Capital Management New York $3.09B AUM 31.19% 1-Year Est. Return
WA
Whitebox Advisors Minneapolis, Minnesota $8.12B AUM 15.85% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
NGA
New Generation Advisors Manchester, Massachusetts $45.6M AUM 15.43% 1-Year Est. Return
MFP
Michael F. Price $846M AUM 0.07% 1-Year Est. Return

Stratos Wealth Partners's GCVRZ Position: Q4 2018 in Review

Stratos Wealth Partners sold out of Sanofi Contingent Value Rights (GCVRZ) in Q4 2018, closing a stake of 297 shares.

Stratos Wealth Partners first reported a position in GCVRZ in Q4 2017 and held it in 3 quarters. The position peaked at $0 in Q3 2018. 103 funds tracked by Wall St. Rank hold GCVRZ as of Q4 2018.

  • Stratos Wealth Partners reported no remaining Sanofi Contingent Value Rights position as of Q4 2018 after selling out during the quarter.
  • Stratos Wealth Partners sold 297 Sanofi Contingent Value Rights shares in Q4 2018.
  • Stratos Wealth Partners first reported a position in Sanofi Contingent Value Rights in Q4 2017 and held it in 3 quarters.
  • Stratos Wealth Partners's Sanofi Contingent Value Rights position peaked at $0 in Q3 2018.
  • 103 funds tracked by Wall St. Rank held Sanofi Contingent Value Rights as of Q4 2018.

Based on Stratos Wealth Partners's 13F filing for Q4 2018, filed 8 Feb 2019.